Ligand Pharmaceuticals Inc (LGND)
EBITDA
$72.52M
Quarterly · Period ending: · USD
LGND EBITDA
Latest reported$72.52Mperiod ending
Latest reported$72.52Mperiod ending
LGND Quarterly EBITDA (-$5.20M → $72.52M)
Quarterly EBITDA
High-resolution chart · PNG
LGND ebitda history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -5,830,000 | |
| -6,669,000 | |
| -15,250,000 | |
| -10,436,000 | |
| -9,550,000 | |
| -7,131,000 | |
| -14,900,000 | |
| -11,035,000 | |
| -13,400,000 | |
| -9,600,000 | |
| -21,600,000 | |
| -15,100,000 | |
| -14,400,000 | |
| -10,800,000 | |
| 800,000 | |
| -7,800,000 | |
| -7,100,000 | |
| -6,800,000 | |
| -8,100,000 | |
| -2,400,000 | |
| -7,700,000 | |
| -5,000,000 | |
| -6,200,000 | |
| -6,800,000 | |
| 5,400,000 | |
| -3,400,000 | |
| -3,400,000 | |
| -4,400,000 | |
| -5,400,000 | |
| -5,200,000 |